Cytokinetics, Incorporated
US ˙ NasdaqGS ˙ US23282W6057

Introduction

This page provides a comprehensive analysis of the known insider trading history of David Cragg. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate David Cragg has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:CYTK / Cytokinetics, Incorporated Chief HR & Admin Officer 153,233
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by David Cragg. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases CYTK / Cytokinetics, Incorporated - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in CYTK / Cytokinetics, Incorporated. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CYTK / Cytokinetics, Incorporated Insider Trades
Insider Sales CYTK / Cytokinetics, Incorporated - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in CYTK / Cytokinetics, Incorporated. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2021-11-09 CYTK Cragg David 24,519 41.7602 24,519 41.7602 1,023,918 79 29.7400 -294,723 -28.78
2021-11-09 CYTK Cragg David 20,481 41.7602 20,481 41.7602 855,291

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CYTK / Cytokinetics, Incorporated Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by David Cragg as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2022-03-08 2022-03-07 4 CYTK CYTOKINETICS INC
Common Stock
F - Taxes -5,399 153,233 -3.40 36.83 -198,845 5,643,571
2022-03-03 2022-03-02 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
A - Award 46,138 46,138 37.63 1,736,173 1,736,173
2022-03-03 2022-03-02 4 CYTK CYTOKINETICS INC
Incentive Stock Option (right to buy)
A - Award 3,862 3,862 37.63 145,327 145,327
2022-03-03 2022-03-02 4 CYTK CYTOKINETICS INC
Common Stock
A - Award 20,000 158,632 14.43
2022-03-03 2022-03-02 4 CYTK CYTOKINETICS INC
Common Stock
F - Taxes -3,458 138,632 -2.43 37.63 -130,125 5,216,722
2022-03-01 2022-02-28 4 CYTK CYTOKINETICS INC
Common Stock
F - Taxes -2,071 142,090 -1.44 35.32 -73,148 5,018,619
2022-02-17 2022-02-16 4 CYTK CYTOKINETICS INC
Common Stock
A - Award 3,125 144,161 2.22
2022-02-17 2022-02-16 4 CYTK CYTOKINETICS INC
Common Stock
A - Award 1,883 141,036 1.35
2021-11-09 2021-11-09 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -24,519 0 -100.00
2021-11-09 2021-11-09 4 CYTK CYTOKINETICS INC
Incentive Stock Option (right to buy)
M - Exercise -20,481 0 -100.00
2021-11-09 2021-11-09 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale -20,481 138,704 -12.87 41.76 -855,291 5,792,307
2021-11-09 2021-11-09 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise 20,481 159,185 14.77 9.65 197,642 1,536,135
2021-11-09 2021-11-09 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale -24,519 138,704 -15.02 41.76 -1,023,918 5,792,307
2021-11-09 2021-11-09 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise 24,519 163,223 17.68 9.65 236,608 1,575,102
2021-11-02 2021-11-01 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -6,675 0 -100.00
2021-11-02 2021-11-01 4 CYTK CYTOKINETICS INC
Incentive Stock Option (right to buy)
M - Exercise X -18,325 0 -100.00
2021-11-02 2021-11-01 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale X -18,325 138,704 -11.67 34.89 -639,352 4,839,327
2021-11-02 2021-11-01 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise X 18,325 157,029 13.21 6.00 109,950 942,174
2021-11-02 2021-11-01 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale X -6,675 138,704 -4.59 34.89 -232,888 4,839,327
2021-11-02 2021-11-01 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise X 6,675 145,379 4.81 6.00 40,050 872,274
2021-10-01 2021-10-01 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale X -7,569 137,123 -5.23 35.14 -265,990 4,818,776
2021-09-02 2021-09-01 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale X -7,850 144,692 -5.15 32.78 -257,311 4,742,787
2021-08-02 2021-08-02 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale X -2,616 152,542 -1.69 29.67 -77,617 4,525,921
2021-07-02 2021-07-01 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale X -6,013 155,158 -3.73 19.87 -119,479 3,083,005
2021-06-02 2021-06-01 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -6,562 0 -100.00
2021-06-02 2021-06-01 4 CYTK CYTOKINETICS INC
Incentive Stock Option (right to buy)
M - Exercise X -8,437 0 -100.00
2021-06-02 2021-06-01 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale X -8,437 161,171 -4.97 21.63 -182,470 3,485,710
2021-06-02 2021-06-01 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise X 8,437 169,608 5.23 6.30 53,153 1,068,530
2021-06-02 2021-06-01 4 CYTK CYTOKINETICS INC
Common Stock
S - Sale X -6,562 161,171 -3.91 21.63 -141,919 3,485,710
2021-06-02 2021-06-01 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise X 6,562 167,733 4.07 6.30 41,341 1,056,718
2021-03-09 2021-03-08 4 CYTK CYTOKINETICS INC
Common Stock
F - Taxes -4,150 160,625 -2.52 19.19 -79,638 3,082,394
2021-03-04 2021-03-02 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
A - Award 34,879 34,879 19.42 677,350 677,350
2021-03-04 2021-03-02 4 CYTK CYTOKINETICS INC
Incentive Stock Option (right to buy)
A - Award 10,121 10,121 19.42 196,550 196,550
2021-03-04 2021-03-02 4 CYTK CYTOKINETICS INC
Common Stock
A - Award 25,000 164,775 17.89
2021-03-02 2021-03-01 4 CYTK CYTOKINETICS INC
Common Stock
F - Taxes -2,075 139,775 -1.46 19.66 -40,794 2,747,976
2021-03-01 2021-02-26 4 CYTK CYTOKINETICS INC
Common Stock
F - Taxes -4,379 141,850 -2.99 18.73 -82,019 2,656,850
2020-12-17 2020-12-15 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -9,243 0 -100.00
2020-12-17 2020-12-15 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -7,423 9,243 -44.54
2020-12-17 2020-12-15 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
C - Conversion 7,423 16,666 80.31
2020-12-17 2020-12-15 4 CYTK CYTOKINETICS INC
Incentive Stock Option (right to buy)
C - Conversion -7,423 1 -99.99
2020-12-17 2020-12-15 4 CYTK CYTOKINETICS INC
Common Stock
F - Taxes -5,908 146,229 -3.88 21.00 -124,068 3,070,809
2020-12-17 2020-12-15 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise 9,243 152,137 6.47 9.42 87,069 1,433,131
2020-12-17 2020-12-15 4 CYTK CYTOKINETICS INC
Common Stock
F - Taxes -4,745 142,894 -3.21 21.00 -99,645 3,000,774
2020-12-17 2020-12-15 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise 7,423 147,639 5.29 9.42 69,925 1,390,759
2020-03-09 2020-03-06 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
A - Award 50,408 50,408 14.40 725,875 725,875
2020-03-09 2020-03-06 4 CYTK CYTOKINETICS INC
Incentive Stock Option (right to buy)
A - Award 9,592 9,592 14.40 138,125 138,125
2020-03-09 2020-03-06 4 CYTK CYTOKINETICS INC
Common Stock
A - Award 30,000 139,098 27.50
2020-03-03 2020-02-28 4 CYTK CYTOKINETICS INC
Common Stock
F - Taxes -1,384 109,098 -1.25 13.94 -19,293 1,520,826
2020-03-02 2020-02-27 4 CYTK CYTOKINETICS INC
Common Stock
F - Taxes -4,150 110,482 -3.62 13.94 -57,851 1,540,119
2020-02-28 2020-02-26 4 CYTK CYTOKINETICS INC
Common Stock
F - Taxes -4,431 114,632 -3.72 14.06 -62,322 1,612,299
2019-03-04 2019-02-26 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
A - Award 33,889 33,889 7.14 241,967 241,967
2019-03-04 2019-02-26 4 CYTK CYTOKINETICS INC
Incentive Stock Option (right to buy)
A - Award 16,111 16,111 7.14 115,033 115,033
2019-03-04 2019-02-26 4 CYTK CYTOKINETICS INC
Common Stock
A - Award 30,000 116,783 34.57
2018-03-01 2018-02-28 4 CYTK CYTOKINETICS INC
Common Stock
F - Taxes -2,730 85,865 -3.08 7.75 -21,158 665,454
2018-03-01 2018-02-28 4 CYTK CYTOKINETICS INC
Common Stock
F - Taxes -5,741 88,595 -6.09 7.75 -44,493 686,611
2018-03-01 2018-02-28 4 CYTK CYTOKINETICS INC
Common Stock
A - Award 15,000 94,336 18.91 0.00 15 94
2018-03-01 2018-02-27 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
A - Award 24,268 24,268
2018-03-01 2018-02-27 4 CYTK CYTOKINETICS INC
Incentive Stock Option (right to buy)
A - Award 15,732 15,732
2018-03-01 2018-02-27 4 CYTK CYTOKINETICS INC
Common Stock
A - Award 30,000 79,336 60.81 0.00 30 79
2017-03-02 2017-02-28 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
A - Award 14,166 14,166
2017-03-02 2017-02-28 4 CYTK CYTOKINETICS INC
Incentive Stock Option (right to buy)
A - Award 5,834 5,834
2017-03-02 2017-02-28 4 CYTK CYTOKINETICS INC
Common Stock
A - Award 20,000 48,018 71.38 0.00 20 48
2017-03-02 2017-02-28 4 CYTK CYTOKINETICS INC
Common Stock
F - Taxes -6,008 28,018 -17.66 10.60 -63,685 296,991
2017-03-02 2017-02-28 4 CYTK CYTOKINETICS INC
Common Stock
A - Award 15,000 34,026 78.84 0.00 15 34
2016-02-25 2016-02-23 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
A - Award 39,359 39,359
2016-02-25 2016-02-23 4 CYTK CYTOKINETICS INC
Incentive Stock Option (right to buy)
A - Award 15,641 15,641
2015-03-02 2015-02-26 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
A - Award 28,333 28,333
2015-03-02 2015-02-26 4 CYTK CYTOKINETICS INC
Incentive Stock Option (right to buy)
A - Award 11,667 11,667
2014-02-26 2014-02-24 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
A - Award 24,519 24,519
2014-02-26 2014-02-24 4 CYTK CYTOKINETICS INC
Incentive Stock Option (right to buy)
A - Award 20,481 20,481
2013-09-05 2013-09-03 4 CYTK CYTOKINETICS INC
Restricted Stock Units
M - Exercise -10,416 0 -100.00
2013-09-05 2013-09-03 4 CYTK CYTOKINETICS INC
Common Stock
F - Taxes -3,913 16,266 -19.39 7.65 -29,934 124,435
2013-09-05 2013-09-03 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise 10,416 20,179 106.69
2013-03-07 2013-03-05 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
A - Award 40,050 40,050
2013-03-07 2013-03-05 4 CYTK CYTOKINETICS INC
Incentive Stock Option (right to buy)
A - Award 109,950 109,950
2012-09-05 2012-09-04 4 CYTK CYTOKINETICS INC
Restricted Stock Units
M - Exercise -62,500 62,500 -50.00
2012-09-05 2012-09-04 4 CYTK CYTOKINETICS INC
Common Stock
F - Taxes -22,894 56,081 -28.99 0.76 -17,395 42,610
2012-09-05 2012-09-04 4 CYTK CYTOKINETICS INC
Common Stock
M - Exercise 62,500 78,975 379.36
2012-03-07 2012-03-05 4 CYTK CYTOKINETICS INC
Non-Qualified Stock Option (right to buy)
A - Award 39,375 39,375
2012-03-07 2012-03-05 4 CYTK CYTOKINETICS INC
Incentive Stock Option (right to buy)
A - Award 50,625 50,625
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)